SeaStar Medical Holding Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICU research report →
About the company
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome.
- CEO
- Eric Schlorff
- IPO
- 2021
- Employees
- 19
- HQ
- Denver, CO, US
Price Chart
- Market Cap
- $13.96M
- P/E
- -1.20
- P/S
- 9.72
- P/B
- 26.35
- EV/EBITDA
- -0.41
- Div Yield
- 0.00%
- Gross Margin
- 93.11%
- Op Margin
- -832.45%
- Net Margin
- -828.62%
- ROE
- -146.29%
- ROIC
- -156.34%
- Revenue
- $1.23M · 814.07%
- Net Income
- $-12,150,000 · 51.07%
- EPS
- $-5.86 · 91.16%
- Op Income
- $-12,175,000
- FCF YoY
- 15.04%
- 52W High
- $12.50
- 52W Low
- $2.07
- 50D MA
- $3.76
- 200D MA
- $3.88
- Beta
- -1.03
- Avg Volume
- 104.07K
Get TickerSpark's AI analysis on ICU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Schlorff Eric | other | 10,288 |
| Jul 1, 26 | Chung Kevin | other | 7,202 |
| Jul 1, 26 | Vincent Bernadette N | other | 4,000 |
| Jul 1, 26 | Neuman John | other | 4,000 |
| Jul 1, 26 | Van Heel Kenneth | other | 4,000 |
| Jul 1, 26 | Baird Jennifer A | other | 4,000 |
| Feb 6, 26 | Van Heel Kenneth | other | 3,000 |
| Feb 6, 26 | Neuman John | other | 3,000 |
| Feb 6, 26 | Vincent Bernadette N | other | 3,000 |
| Feb 6, 26 | Baird Jennifer A | other | 3,000 |
Our ICU coverage
Recent articles, reports, and earnings notes.
No research on ICU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ICU report →Similar companies
Peers in the same neighborhood.